Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic mutation analysis of 22 patients with congenital absence of vas deferens: a single-center study†. | Biol Reprod | 2022 | 34673937 | PubTator, text mining | PubMed |
| Hypoxia signaling: Challenges and opportunities for cancer therapy. | Semin Cancer Biol | 2022 | 34628029 | PubTator, text mining | PubMed |
| Matrine injection inhibits pancreatic cancer growth via modulating carbonic anhydrases- a network pharmacology-based study with in vitro validation. | J Ethnopharmacol | 2022 | 34597654 | PubTator, text mining | PubMed |
| Computational modeling predicts potential effects of the herbal infusion "horchata" against COVID-19. | Food Chem | 2022 | 34311241 | PubTator, text mining | PubMed |
| Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations. | Adv Healthc Mater | 2022 | 34297485 | PubTator, text mining | PubMed |
| Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis. | Dig Dis Sci | 2022 | 33939141 | PubTator, text mining | PubMed |
| Molecular and cellular paradigms of multidrug resistance in cancer. | Cancer Rep (Hoboken) | 2022 | 33052041 | PubTator, text mining | PubMed |
| Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer. | Cancer Drug Resist | 2021 | 35582034 | PubTator, text mining | PubMed |
| Regulation of cancer stem cells in triple negative breast cancer. | Cancer Drug Resist | 2021 | 35582030 | PubTator, text mining | PubMed |
| Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. | RSC Adv | 2021 | 35479426 | PubTator, text mining | PubMed |
| Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration. | Front Cell Dev Biol | 2021 | 35359916 | PubTator, text mining | PubMed |
| The Neuroprotective Effects of Coreopsis tinctoria and Its Mechanism: Interpretation of Network Pharmacological and Experimental Data. | Front Pharmacol | 2021 | 35222009 | PubTator, text mining | PubMed |
| IGF Signaling in Intervertebral Disc Health and Disease. | Front Cell Dev Biol | 2021 | 35178405 | PubTator, text mining | PubMed |
| CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer. | Front Oncol | 2021 | 35155218 | PubTator, text mining | PubMed |
| Systematically Displaying the Pathogenesis of Keratoconus via Multi-Level Related Gene Enrichment-Based Review. | Front Med (Lausanne) | 2021 | 35141241 | PubTator, text mining | PubMed |
| TISSUE CLEARING. | Nat Rev Methods Primers | 2021 | 35128463 | PubTator, text mining | PubMed |
| The Polygenic Map of Keloid Fibroblasts Reveals Fibrosis-Associated Gene Alterations in Inflammation and Immune Responses. | Front Immunol | 2021 | 35082796 | PubTator, text mining | PubMed |
| Synthesis and Characterization of Blended Cellulose Acetate Membranes. | Polymers (Basel) | 2021 | 35012026 | PubTator, text mining | PubMed |
| Expression of Proton-Sensitive GPR31, GPR151, TASK1 and TASK3 in Common Skin Tumors. | Cells | 2021 | 35011589 | PubTator, text mining | PubMed |
| Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms. | Int J Mol Sci | 2021 | 35008884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=24